<DOC>
	<DOCNO>NCT02797574</DOCNO>
	<brief_summary>The purpose study investigate stress response pathways tissue melanocytes patient vitiligo . Investigators collect evidence UPR stress response activation tissue melanocytes patient vitiligo . Individuals vitiligo punch biopsy study stress response UPR activation NF-κB signal test hypothesis . In order characterize difference disease normal state , second arm control individual ( Arm 2 ) recruit .</brief_summary>
	<brief_title>Stress Response Pathways Vitiligo</brief_title>
	<detailed_description>Identifying role NF-κB signal vitiligo may improve therapy disfigure disorder . Current treatment vary effectiveness may always long lasting case . The NF-κB pathway IL-6 target several FDA approve drug , thus open new therapeutic avenue .</detailed_description>
	<mesh_term>Vitiligo</mesh_term>
	<criteria>To eligible participation , subject must meet following criterion : Must clinical exam consistent diagnosis nonsegmental vitiligo Must normally pigment No clinical presentation vitiligo Outside specify age range No clinical diagnosis vitiligo Use systemic therapy , include limited methotrexate , etretinate , cyclosporine , calcineurin inhibitor and/ vitamin D analog within 4 week enrollment Use topical steroid topical immunodilators biopsy site within 4 week enrollment History keloid hypertrophic scar Patients pacemaker defibrillator heart valves Patients Plavix , Warfarin similar anticoagulation medicine Pregnant females Lactating woman Allergies sensitivity lidocaine epinephrine Outside specify age range Abnormally pigment potential biopsy site ( nonvitiligo ) Clinical presentation vitiligo Use systemic therapy , include limited methotrexate , etretinate , cyclosporine , calcineuron inhibitor and/ vitamin D analog within 4 week enrollment Use topical steroid topical immunodilators biopsy site within 4 week enrollment History keloid hypertrophic scar</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>